Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may both prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer.
GLP-1 medications are sold under several different brand names and treat diabetes, obesity and sleep apnea. The drugs' affect on cancer is in very early stages of research.
Michael Siluk/Universal Images Group via Getty Images
hide caption
toggle caption
Michael Siluk/Universal Images Group via Getty Images
Here’s how GLP-1 drugs could save your life, as well as make you slim
New Study Suggests GLP-1 Use Might Lower Your Chances Of Developing This Common Cancer
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
This Popular Medication Might Reduce The Chance Of Developing Breast Cancer By 30%
Large Study Links GLP-1s to Lower Risk of Multiple Cancers
Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
Weight loss jabs linked to dramatic fall in obesity cancer risk
Why drugs like Ozempic might reduce cancer risk
Popular Weight Loss Drugs Linked to Lower Risk of Breast Cancer
Weight-loss drugs linked to lower breast cancer risk, study finds
Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress…
GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different…
GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical…
Researchers believe the popular medication should be further studied as a cancer prevention tool.
Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in…
A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.
